Cargando…

A novel nomogram can predict pathological T3a upstaged from clinical T1a in localized renal cell carcinoma

HYPOTHESIS: Nomogram can be built to predict the pathological T3a upstaging from clinical T1a in patients with localized renal cell carcinoma before surgery. PURPOSE: Renal cell carcinoma (RCC) patients with clinical T1a (cT1a) disease who are upstaged to pathological T3a (pT3a) have reduced surviva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Chuanzhen, Kang, Xiangpeng, Shang, Bingqing, Shou, Jianzhong, Shi, Hongzhe, Jiang, Weixing, Xie, Ruiyang, Zhang, Jin, Zhang, Lianyu, Zheng, Shan, Bi, Xingang, Li, Changling, Ma, Jianhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388175/ https://www.ncbi.nlm.nih.gov/pubmed/35838503 http://dx.doi.org/10.1590/S1677-5538.IBJU.2021.0859

Ejemplares similares

Novel cut‐off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long‐term, follow‐up, retrospective study
por: Cao, Chuanzhen, et al.
Publicado: (2021)

Promising Immunotherapy in Metastatic Testicular Sex Cord Stromal Tumours After First-Line Chemotherapy
por: Shang, Bingqing, et al.
Publicado: (2022)

Optimizing targeted drug selection in combination therapy for patients with advanced or metastatic renal cell carcinoma: A systematic review and network meta‐analysis of safety
por: Xie, Ruiyang, et al.
Publicado: (2022)

Prognostic Significance of NLR About NETosis and Lymphocytes Perturbations in Localized Renal Cell Carcinoma With Tumor Thrombus
por: Shang, Bingqing, et al.
Publicado: (2021)

Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma
por: Xie, Ruiyang, et al.
Publicado: (2022)

Prognostic value of the ratio of maximum to minimum diameter of primary tumor in metastatic clear cell renal cell carcinoma
por: Shi, Hongzhe, et al.
Publicado: (2022)

Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysis
por: Xie, Ruiyang, et al.
Publicado: (2021)

Combination of Hematology Indicators and Oncological Characteristics as a New Promising Prognostic Factor in Localized Clear Cell Renal Cell Carcinoma
por: Kang, Xiangpeng, et al.
Publicado: (2020)

Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target
por: Shang, Bingqing, et al.
Publicado: (2023)

Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents
por: Cao, Chuanzhen, et al.
Publicado: (2022)

Impact of Primary Tumor Size on Prognosis in Patients With Metastatic Renal Cell Carcinoma Receiving Cytoreductive Nephrectomy: A Population Study of a Chinese Center and the US SEER Database
por: Jiang, Weixing, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy–Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study
por: Shi, Hongzhe, et al.
Publicado: (2021)

Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging
por: Jeong, Seung-hwan, et al.
Publicado: (2016)

Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus
por: Cao, Chuanzhen, et al.
Publicado: (2019)

A morphology-based nephrometry score to predict pathological upstaging to T3 renal cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2022)

US "likely to upstage CERN accelerator"
por: Turney, J E
Publicado: (1984)

The dilemma of partial nephrectomy and surgical upstaging
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2022)

The Preoperative Predictive Factors for Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma
por: Fukui, Shinji, et al.
Publicado: (2019)

Pathological upgrading and upstaging at radical prostatectomy in Jamaican men with low-risk prostate cancer
por: Morrison, Belinda F, et al.
Publicado: (2019)

Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma
por: Guo, Liping, et al.
Publicado: (2020)

Efficacy and safety of surgery in renal carcinoma patients 75 years and older: a retrospective analysis
por: Bai, Hongsong, et al.
Publicado: (2022)

Lung cancer upstaging due to the COVID-19 pandemic
por: Vella, Claire, et al.
Publicado: (2021)

Copy number variation of urine exfoliated cells by low-coverage whole genome sequencing for diagnosis of prostate adenocarcinoma: a prospective cohort study
por: Guan, Youyan, et al.
Publicado: (2022)

Impact of pathological T3a upstaging on oncological outcomes of clinical T1 renal cell carcinoma: a meta-analysis
por: Chen, Luyao, et al.
Publicado: (2019)

Added Value of Systemic Inflammation Markers in Predicting Clinical Stage T1 Renal Cell Carcinoma Pathologically Upstaged to T3a
por: Liu, Hailang, et al.
Publicado: (2021)

Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging
por: Bakavicius, Arnas, et al.
Publicado: (2019)

Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
por: Flammia, Rocco S., et al.
Publicado: (2022)

Old men with prostate cancer have higher risk of Gleason score upgrading and pathological upstaging after initial diagnosis: a systematic review and meta-analysis
por: Wang, Xiaochuan, et al.
Publicado: (2021)

A component of lobular carcinoma in clinically lymph node–negative patients predicts for an increased likelihood of upstaging to pathologic stage III breast cancer
por: Van Wyhe, Renae D., et al.
Publicado: (2018)

The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival
por: Bakavičius, Arnas, et al.
Publicado: (2020)

Upgrading and upstaging of low-risk prostate cancer among Korean patients: a multicenter study
por: Hwang, Insang, et al.
Publicado: (2015)

A preoperative model to predict pT3 upstaging in clinically localized renal cell carcinoma
por: de la Barra, Carlos Calvo, et al.
Publicado: (2020)

Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy
por: Gao, Yuan, et al.
Publicado: (2016)

PET-CT upstaging of unilateral operable breast cancer and its correlation with molecular subtypes
por: Singh, Srishti, et al.
Publicado: (2020)

CYR61 as a potential biomarker for the preoperative identification of muscle-invasive bladder cancers
por: Chen, Huang, et al.
Publicado: (2021)

P1.12-05 Prediction of Clinically Significant Pathological Upstaging in Resected Lung Cancer: Insight from COVID-19 Pandemic (1st wave)
por: Zhang, Y.Z., et al.
Publicado: (2022)

The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance
por: Murray, Nigel P, et al.
Publicado: (2017)

Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance
por: Jeon, Hwang Gyun, et al.
Publicado: (2017)

Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy
por: Si, Jing, et al.
Publicado: (2019)

Lymphatic Invasion Might Be Considered as an Upstaging Factor in N0 and N1 Gastric Cancer †
por: Choi, Won Hyuk, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2mt951u9m15kejq0ncckdjaf1v